Topic Editors

Department of Translational Medicine (DIMET), University of Eastern Piedmont, 28100 Novara, Italy
Dr. Roberto Coppo
Department of Clinical Bio-Resource Research and Development, Graduate School of Medicine, Kyoto University, Kyoto, Japan
Dr. Federico Virga
Spanish National Centre for Cardiovascular Research (CNIC), 28029 Madrid, Spain

miRNAs in Pathophysiology of Disease

Abstract submission deadline
12 September 2024
Manuscript submission deadline
12 November 2024
Viewed by
10888

Topic Information

Dear Colleagues,

miRNAs (miRs) are small non-coding RNAs that negatively regulate their target mRNAs, mostly by binding to their 3′UTRs. First discovered in C. elegans, miRs have been identified and studied in plants, animals and even in viruses. As the research on miRs has grown over the past decade, new information about their involvement in multiple physiological cell functions is beginning to be elucidated. As a matter of fact, their dysregulation can lead to serious pathologies such as cancer, cardiovascular disease, diabetes, mental disorders and viral infection. There is a great demand to understand the principles of context-specific miRNA target recognition in order to elucidate their role in the development and pathophysiology of diseases, as well as to improve miR detection methods and design future therapeutic strategies. We are pleased to invite you to the MDPI Topic collections “miRNAs in Pathophysiology of Disease”. MDPI Topics are collections of articles that concentrate on specific cutting-edge, interdisciplinary themes published in different MDPI journals. The aim of the current topic is to allow authors from different research areas (such as cancer, immunology, neurology, metabolism, engineering and biophysics) to focus on the role of miRs in diseases, describe the multi-disciplinary applications of their research and develop new ideas. For this collection, papers should be submitted in one of the following journals: Cancers, Biology, Current Oncology, Diseases or Onco. In this Topic, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following: cancer progression, inflammatory and infectious diseases, metabolic disorders, miRNA-based biomarkers and therapies, new technologies for miRNA detection and new target prediction tools. We look forward to receiving your contributions.

Dr. Francesca Orso
Dr. Roberto Coppo
Dr. Federico Virga
Topic Editors

Keywords

  • cancer
  • metastasis
  • inflammatory disease
  • infectious disease
  • metabolic disorders
  • genetic disease
  • neurological disease
  • miRNA therapy
  • miRNA biomarker
  • miRNA detection

Participating Journals

Journal Name Impact Factor CiteScore Launched Year First Decision (median) APC
Biology
biology
4.2 4.0 2012 18.7 Days CHF 2700 Submit
Cancers
cancers
5.2 7.4 2009 17.9 Days CHF 2900 Submit
Current Oncology
curroncol
2.6 2.6 1994 18 Days CHF 2200 Submit
Diseases
diseases
3.7 - 2013 18.8 Days CHF 1800 Submit
Onco
onco
- - 2021 18.3 Days CHF 1000 Submit

Preprints.org is a multidiscipline platform providing preprint service that is dedicated to sharing your research from the start and empowering your research journey.

MDPI Topics is cooperating with Preprints.org and has built a direct connection between MDPI journals and Preprints.org. Authors are encouraged to enjoy the benefits by posting a preprint at Preprints.org prior to publication:

  1. Immediately share your ideas ahead of publication and establish your research priority;
  2. Protect your idea from being stolen with this time-stamped preprint article;
  3. Enhance the exposure and impact of your research;
  4. Receive feedback from your peers in advance;
  5. Have it indexed in Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers (5 papers)

Order results
Result details
Journals
Select all
Export citation of selected articles as:
19 pages, 382 KiB  
Review
MicroRNAs in Juvenile Idiopathic Arthritis: State of the Art and Future Perspectives
by Simone Pelassa, Federica Raggi, Chiara Rossi and Maria Carla Bosco
Biology 2023, 12(7), 991; https://doi.org/10.3390/biology12070991 - 12 Jul 2023
Viewed by 1039
Abstract
Juvenile Idiopathic Arthritis (JIA) represents the most common chronic pediatric arthritis in Western countries and a leading cause of disability in children. Despite recent clinical achievements, patient management is still hindered by a lack of diagnostic/prognostic biomarkers and targeted treatment protocols. MicroRNAs (miRNAs) [...] Read more.
Juvenile Idiopathic Arthritis (JIA) represents the most common chronic pediatric arthritis in Western countries and a leading cause of disability in children. Despite recent clinical achievements, patient management is still hindered by a lack of diagnostic/prognostic biomarkers and targeted treatment protocols. MicroRNAs (miRNAs) are short non-coding RNAs playing a key role in gene regulation, and their involvement in many pathologies has been widely reported in the literature. In recent decades, miRNA’s contribution to the regulation of the immune system and the pathogenesis of autoimmune diseases has been demonstrated. Furthermore, miRNAs isolated from patients’ biological samples are currently under investigation for their potential as novel biomarkers. This review aims to provide an overview of the state of the art on miRNA investigation in JIA. The literature addressing the expression of miRNAs in different types of biological samples isolated from JIA patients was reviewed, focusing in particular on their potential application as diagnostic/prognostic biomarkers. The role of miRNAs in the regulation of immune responses in affected joints will also be discussed along with their potential utility as markers of patients’ responses to therapeutic approaches. This information will be of value to investigators in the field of pediatric rheumatology, encouraging further research to increase our knowledge of miRNAs’ potential for future clinical applications in JIA. Full article
(This article belongs to the Topic miRNAs in Pathophysiology of Disease)
Show Figures

Graphical abstract

21 pages, 2697 KiB  
Article
MicroRNA-483-5p Inhibits Hepatocellular Carcinoma Cell Proliferation, Cell Steatosis, and Fibrosis by Targeting PPARα and TIMP2
by Suryakant Niture, Sashi Gadi, Qi Qi, Maxwell Afari Gyamfi, Rency S. Varghese, Leslimar Rios-Colon, Uchechukwu Chimeh, Vandana, Habtom W. Ressom and Deepak Kumar
Cancers 2023, 15(6), 1715; https://doi.org/10.3390/cancers15061715 - 10 Mar 2023
Cited by 8 | Viewed by 1967
Abstract
MicroRNAs (miRNAs) are small non-coding RNA molecules that bind with the 3′ untranslated regions (UTRs) of genes to regulate expression. Downregulation of miR-483-5p (miR-483) is associated with the progression of hepatocellular carcinoma (HCC). However, the significant roles of miR-483 in nonalcoholic fatty liver [...] Read more.
MicroRNAs (miRNAs) are small non-coding RNA molecules that bind with the 3′ untranslated regions (UTRs) of genes to regulate expression. Downregulation of miR-483-5p (miR-483) is associated with the progression of hepatocellular carcinoma (HCC). However, the significant roles of miR-483 in nonalcoholic fatty liver disease (NAFLD), alcoholic fatty liver diseases (AFLD), and HCC remain elusive. In the current study, we investigated the biological significance of miR-483 in NAFLD, AFLD, and HCC in vitro and in vivo. The downregulation of miR-483 expression in HCC patients’ tumor samples was associated with Notch 3 upregulation. Overexpression of miR-483 in a human bipotent progenitor liver cell line HepaRG and HCC cells dysregulated Notch signaling, inhibited cell proliferation/migration, induced apoptosis, and increased sensitivity towards antineoplastic agents sorafenib/regorafenib. Interestingly, the inactivation of miR-483 upregulated cell steatosis and fibrosis signaling by modulation of lipogenic and fibrosis gene expression. Mechanistically, miR-483 targets PPARα and TIMP2 gene expression, which leads to the suppression of cell steatosis and fibrosis. The downregulation of miR-483 was observed in mice liver fed with a high-fat diet (HFD) or a standard Lieber-Decarli liquid diet containing 5% alcohol, leading to increased hepatic steatosis/fibrosis. Our data suggest that miR-483 inhibits cell steatosis and fibrogenic signaling and functions as a tumor suppressor in HCC. Therefore, miR-483 may be a novel therapeutic target for NAFLD/AFLD/HCC management in patients with fatty liver diseases and HCC. Full article
(This article belongs to the Topic miRNAs in Pathophysiology of Disease)
Show Figures

Figure 1

18 pages, 835 KiB  
Review
Obstructive Sleep Apnea: A Look towards Micro-RNAs as Biomarkers of the Future
by Giorgia Moriondo, Piera Soccio, Pasquale Tondo, Giulia Scioscia, Roberto Sabato, Maria Pia Foschino Barbaro and Donato Lacedonia
Biology 2023, 12(1), 66; https://doi.org/10.3390/biology12010066 - 30 Dec 2022
Cited by 3 | Viewed by 1655
Abstract
Sleep-disordered breathing (SDB) includes a broad spectrum of diseases, of which obstructive sleep apnea syndrome (OSA) is the most clinically significant manifestation. OSA is a respiratory disorder characterized by episodes of complete or partial obstruction of the upper airways that disturb ventilation and [...] Read more.
Sleep-disordered breathing (SDB) includes a broad spectrum of diseases, of which obstructive sleep apnea syndrome (OSA) is the most clinically significant manifestation. OSA is a respiratory disorder characterized by episodes of complete or partial obstruction of the upper airways that disturb ventilation and sleep architecture. In recent years, interest in the clinical implications of OSA seems to have increased, probably due to the numerous studies that have shown the existence of an important correlation between OSA and cardiovascular, dysmetabolic, and neoplastic changes. The guidelines currently available highlight the importance of diagnosis and effective treatment for OSA, underlining the need for new biomarkers that are useful in clinical practice, feasible, and reproducible to guide medical decision making. In this review, we intend to provide an overview of the potential role of microRNAs as new indicators for OSA management. MicroRNAs (miRNAs) are small non-coding RNA molecules that play an important role in RNA silencing and regulation of gene expression at the post-transcriptional level. These can bind specifically to their target genes by forming silencing complexes, thus inducing degradation or altered gene expression. A wide range of miRNAs have been extensively studied in a variety of diseases including cancer, and recently, miRNAs have been shown to have enormous potential to function as diagnostic and clinical biomarkers of disease. This review includes recent studies that establish the inevitable role of miRNAs in the pathogenesis of OSA. Full article
(This article belongs to the Topic miRNAs in Pathophysiology of Disease)
Show Figures

Figure 1

16 pages, 5516 KiB  
Article
Evaluation of miRNA Expression in Glioblastoma Stem-Like Cells: A Comparison between Normoxia and Hypoxia Microenvironment
by Lucy Wanjiku Macharia, Wanjiru Muriithi, Dennis Kirii Nyaga, Juliana de Mattos Coelho-Aguiar, Tania Cristina Leite de Sampaio e Spohr and Vivaldo Moura-Neto
Onco 2022, 2(2), 113-128; https://doi.org/10.3390/onco2020008 - 26 May 2022
Cited by 1 | Viewed by 2078
Abstract
Purpose: Glioblastoma is an aggressive and incurable brain tumor whose progression is driven in part by glioblastoma stem cells, which are also responsible for the tumor’s low therapy efficacy. The maintenance and expansion of the stem cell population is promoted by the hypoxic [...] Read more.
Purpose: Glioblastoma is an aggressive and incurable brain tumor whose progression is driven in part by glioblastoma stem cells, which are also responsible for the tumor’s low therapy efficacy. The maintenance and expansion of the stem cell population is promoted by the hypoxic microenvironment, where miRNAs play fundamental roles in their survival. Methods: GBM stem-like cells were isolated from three GBM parental cell lines. The stem-like cells were then cultured under normoxic and hypoxic microenvironments followed by investigation of the in vitro “stemness” of the cells. Results: We found miR-128a-3p, 34-5p and 181a-3p to be downregulated and miR-17-5p and miR-221-3p to be upregulated in our stem-like cells compared to the GBMs. When a comparison was made between normoxia and hypoxia, a further fold downregulation was observed for miR-34-5p, miR-128a-3p and miR-181a-3p and a further upregulation was observed for miR-221-3p and 17-5p. There was an increased expression of HIF-1/2, SOX2, OCT4, VEGF, GLUT-1, BCL2 and survivin under hypoxia. Conclusion: Our data suggest that our GBMs were able to grow as stem-like cells and as spheroids. There was a differential expression of miRNAs between the stems and the GBMs and the hypoxia microenvironment influenced further dysregulation of the miRNAs and some selected genes. Full article
(This article belongs to the Topic miRNAs in Pathophysiology of Disease)
Show Figures

Figure 1

14 pages, 1828 KiB  
Article
Assessment of MicroRNAs Associated with Tumor Purity by Random Forest Regression
by Dong-Yeon Nam and Je-Keun Rhee
Biology 2022, 11(5), 787; https://doi.org/10.3390/biology11050787 - 21 May 2022
Cited by 2 | Viewed by 2124
Abstract
Tumor purity refers to the proportion of tumor cells in tumor tissue samples. This value plays an important role in understanding the mechanisms of the tumor microenvironment. Although various attempts have been made to predict tumor purity, attempts to predict tumor purity using [...] Read more.
Tumor purity refers to the proportion of tumor cells in tumor tissue samples. This value plays an important role in understanding the mechanisms of the tumor microenvironment. Although various attempts have been made to predict tumor purity, attempts to predict tumor purity using miRNAs are still lacking. We predicted tumor purity using miRNA expression data for 16 TCGA tumor types using random forest regression. In addition, we identified miRNAs with high feature-importance scores and examined the extent of the change in predictive performance using informative miRNAs. The predictive performance obtained using only 10 miRNAs with high feature importance was close to the result obtained using all miRNAs. Furthermore, we also found genes targeted by miRNAs and confirmed that these genes were mainly related to immune and cancer pathways. Therefore, we found that the miRNA expression data could predict tumor purity well, and the results suggested the possibility that 10 miRNAs with high feature importance could be used as potential markers to predict tumor purity and to help improve our understanding of the tumor microenvironment. Full article
(This article belongs to the Topic miRNAs in Pathophysiology of Disease)
Show Figures

Figure 1

Back to TopTop